dianhydrogalactitol has been researched along with Adenocarcinoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barranco, SC; Boerwinkle, W; Bryant, J; Göhde, W; Guseman, LF; Hokanson, KM; May, JT; Nichols, S; Schumann, J | 1 |
| Bakowski, MT; Crouch, JC | 1 |
| Blessing, JA; Blom, J; Ehrlich, CE; Mangan, C; Stehman, FB | 1 |
| Arsenau, JC; Blessing, J; Lewis, GC; Slavik, M | 1 |
| Baltz, R; Barranco, SC; Boerwinkle, WR; Costanzi, JJ; Guseman, LF; Hokanson, KM; Leipzig, B; May, JT; O'Quinn, AG; Townsend, CM | 1 |
| Baker, LH; Balducci, L; Hoogstraten, B; Ratanatharathorn, V; Talley, RW | 1 |
| Bauer, M; Bennett, JM; Creech, R; Hahn, RG; Wampler, G; Wolter, J | 1 |
1 review(s) available for dianhydrogalactitol and Adenocarcinoma
| Article | Year |
|---|---|
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Random Allocation; Vinblastine; Vindesine | 1983 |
2 trial(s) available for dianhydrogalactitol and Adenocarcinoma
| Article | Year |
|---|---|
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Random Allocation; Vinblastine; Vindesine | 1983 |
Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer.
Topics: Adenocarcinoma; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Drug Evaluation; Etoposide; Humans; Kidney Neoplasms; Megestrol; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Sugar Alcohols | 1979 |
6 other study(ies) available for dianhydrogalactitol and Adenocarcinoma
| Article | Year |
|---|---|
Enhanced cell killing through the use of cell kinetics-directed treatment schedules for two-drug combinations in vitro.
Topics: Adenocarcinoma; Animals; Bleomycin; Carcinoma, Ehrlich Tumor; Cell Cycle; Cell Line; Cell Survival; Cells, Cultured; Cricetinae; Cricetulus; Dianhydrogalactitol; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kinetics; Mice; Ovary; Sugar Alcohols | 1982 |
Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Dianhydrogalactitol; Drug Administration Schedule; Drug Evaluation; Female; Humans; Ovarian Neoplasms; Prognosis; Sugar Alcohols; Uterine Cervical Neoplasms | 1983 |
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Etoposide; Female; Humans; Maytansine; Neoplasm Recurrence, Local; Pelvic Neoplasms; Piperazines; Razoxane; Research Design; Triazines | 1982 |
Use of 1,2:5,6-dianhydrogalactitol in studies on cell kinetics-directed chemotherapy schedules in human tumors in vivo.
Topics: Adenocarcinoma; Biopsy; Carcinoma, Squamous Cell; Cell Cycle; Dianhydrogalactitol; Drug Administration Schedule; Humans; Kinetics; Melanoma; Neoplasms; Sugar Alcohols | 1982 |
Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study.
Topics: Adenocarcinoma; Dianhydrogalactitol; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Sugar Alcohols | 1982 |
Phase II trials of hexamethylmelamine, dianhydrogalactitol, razoxane, and beta-2'-deoxythioguanosine as single agents against advanced measurable tumors of the pancreas. Gastrointestinal Tumor Study Group.
Topics: Adenocarcinoma; Altretamine; Antineoplastic Agents; Deoxyguanosine; Dianhydrogalactitol; Drug Evaluation; Humans; Leukopenia; Pancreatic Neoplasms; Piperazines; Razoxane; Sugar Alcohols; Thionucleosides; Thrombocytopenia; Triazines | 1985 |